login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
IMAGENEBIO INC (IMA) Stock News
USA
- NASDAQ:IMA -
US45175G2075
-
Common Stock
8.49
USD
+0.29 (+3.54%)
Last: 11/11/2025, 1:21:24 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IMA Latest News, Press Relases and Analysis
All
Press Releases
5 days ago - By: ImageneBio, Inc.
ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
5 days ago - By: ImageneBio, Inc.
ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
18 days ago - By: Benzinga
- Mentions:
ATEC
ALB
SQM
PNTG
This Albemarle Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
2 months ago - By: Benzinga
- Mentions:
NBY
NKTR
AEMD
BBLG
...
12 Health Care Stocks Moving In Thursday's Intraday Session
3 months ago - By: Zacks Investment Research
Wall Street Analysts Believe IMAGENEBIO INC (IMA) Could Rally 695.48%: Here's is How to Trade
3 months ago - By: ImageneBio, Inc.
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 months ago - By: ImageneBio, Inc.
Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million
Please enable JavaScript to continue using this application.